BRIDGED BICYCLIC ARYL AND BRIDGED BICYCLIC HETEROARYL SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS
申请人:Rigel Pharmaceuticals, Inc.
公开号:US20140155386A1
公开(公告)日:2014-06-05
Bridged bicyclic aryl or heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases or conditions associated with Axl activity are also disclosed.
本发明公开了桥联的双环芳基或杂环芳基取代的三唑类化合物及含有这些化合物的药物组合物,其可用于抑制受体蛋白酪氨酸激酶Axl的活性。本发明还公开了使用这些化合物治疗与Axl活性相关的疾病或病状的方法。